Ginsenoside Rg1 attenuates right ventricular remodeling in hypoxic pulmonary hypertension and is associated with suppression of HIF-1α–related glycolytic signaling
OBJECTIVES: To determine whether ginsenoside Rg1 attenuates right ventricular remodeling in hypoxic pulmonary hypertension and whether this effect is associated with suppression of HIF-1α-related glycolytic signaling. METHODS: ) for 4 weeks and assigned to control, model, sildenafil, Rg1, or HIF-1α knockdown groups (n=10 per group). Pulmonary function, hemodynamic parameters, right ventricular hypertrophy, histopathology, oxidative stress, apoptosis, immunofluorescence, and protein expression in right ventricular tissue were evaluated. RESULTS: Hypoxia reduced forced expiratory volume in 0.3 s/forced vital capacity and increased mean pulmonary arterial pressure, right ventricular systolic pressure, and right ventricular hypertrophy index. It also induced myocardial disorganization, collagen deposition, oxidative stress, apoptosis, and increased expression of HIF-1α, glucose transporter 1, hexokinase 2, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3, lactate dehydrogenase A, transforming growth factor beta 1, Smad2, and collagen I. Rg1 significantly attenuated these abnormalities, with a pattern broadly comparable to HIF-1α knockdown. CONCLUSIONS: Rg1 attenuated hypoxia-induced right ventricular remodeling and fibrosis and was associated with reduced oxidative injury, apoptosis, and HIF-1α-related glycolytic and profibrotic signaling.
Authors
- Wei Tan (ORCID: https://orcid.org/0000-0002-0831-1909)
- Yanjie Zhu (ORCID: https://orcid.org/0000-0002-9131-689X)
- Jing Fan
- Liya Huang
- Peng He
- Yu Liu
- Guangbo Tan (ORCID: https://orcid.org/0000-0002-9208-4912)
- Wang Liu
Institutions
- Hunan University of Traditional Chinese Medicine (CN)
- Integrated Chinese Medicine (China) (HK)
- Hunan Academy of Traditional Chinese Medicine (CN)
- Hunan Provincial People's Hospital (CN)
Publication Details
- Journal
- Journal of Basic and Clinical Physiology and Pharmacology
- Published
- 2026-05-27
- DOI
- https://doi.org/10.1515/jbcpp-2026-0090
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00